| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A BRILLIANT-BRCA study: residual breast tissue after mastectomy and reconstruction
|
Kaidar-Person, Orit
|
|
|
208 |
2 |
p. 359-367
|
artikel
|
| 2 |
A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer
|
Liang, Emily
|
|
|
208 |
2 |
p. 349-358
|
artikel
|
| 3 |
Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer
|
Wang, Zheng
|
|
|
208 |
2 |
p. 429-440
|
artikel
|
| 4 |
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer
|
Sato, Takumi
|
|
|
208 |
2 |
p. 415-427
|
artikel
|
| 5 |
Contrast-enhanced mammography for surveillance in women with a personal history of breast cancer
|
Matheson, Julia
|
|
|
208 |
2 |
p. 293-305
|
artikel
|
| 6 |
Correction: The novel TP53 3′-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection
|
Zeng, Feng
|
|
|
208 |
2 |
p. 469
|
artikel
|
| 7 |
Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression
|
Chida, Kohei
|
|
|
208 |
2 |
p. 321-331
|
artikel
|
| 8 |
Feasibility and preliminary effects of the Fit2ThriveMB pilot physical activity promotion intervention on physical activity and patient reported outcomes in individuals with metastatic breast cancer
|
Phillips, Siobhan M.
|
|
|
208 |
2 |
p. 391-403
|
artikel
|
| 9 |
First- vs second-line CDK 4/6 inhibitor use for patients with hormone receptor positive, human epidermal growth-factor receptor-2 negative, metastatic breast cancer in the real world setting
|
Kimmick, Gretchen
|
|
|
208 |
2 |
p. 263-273
|
artikel
|
| 10 |
Genomic and transcriptomic profiling of inflammatory breast cancer reveals distinct molecular characteristics to non-inflammatory breast cancers
|
Zhou, Kaiwen
|
|
|
208 |
2 |
p. 441-459
|
artikel
|
| 11 |
Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women
|
Chen, Hsing-Wu
|
|
|
208 |
2 |
p. 283-292
|
artikel
|
| 12 |
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study
|
Magnoni, Francesca
|
|
|
208 |
2 |
p. 333-347
|
artikel
|
| 13 |
Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis
|
Chen, Qian
|
|
|
208 |
2 |
p. 237-251
|
artikel
|
| 14 |
Overcoming technical hurdles in mobile health: insights from the Fit2ThriveMB breast cancer study
|
Guo, Qirui
|
|
|
208 |
2 |
p. 467-468
|
artikel
|
| 15 |
Patterns in use and tolerance of adjuvant neratinib in patients with hormone receptor (HR)-positive, HER2-positive early-stage breast cancer
|
Blanter, Julia
|
|
|
208 |
2 |
p. 461-466
|
artikel
|
| 16 |
Peripheral blood immune parameters, response, and adverse events after neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast cancer
|
Foldi, Julia
|
|
|
208 |
2 |
p. 369-377
|
artikel
|
| 17 |
Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial)
|
Iwamoto, Takayuki
|
|
|
208 |
2 |
p. 253-262
|
artikel
|
| 18 |
Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell death
|
Kumar, Sandeep
|
|
|
208 |
2 |
p. 307-320
|
artikel
|
| 19 |
The heterogeneity of breast cancer metastasis: a bioinformatics analysis utilizing single-cell RNA sequencing data
|
Sanjaya, Ardo
|
|
|
208 |
2 |
p. 379-390
|
artikel
|
| 20 |
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system
|
Bhimani, Jenna
|
|
|
208 |
2 |
p. 405-414
|
artikel
|
| 21 |
Three and twelve-month analysis of the PROM-Q study: comparison of patient-reported outcome measures using the BREAST-Q questionnaire in pre- vs. sub-pectoral implant-based immediate breast reconstruction
|
Rampal, Ritika
|
|
|
208 |
2 |
p. 275-282
|
artikel
|
| 22 |
Trends in HR+ metastatic breast cancer survival before and after CDK4/6 inhibitor introduction in the United States: a SEER registry analysis of patients with HER2− and HER2+ metastatic breast cancer
|
Brufsky, Adam
|
|
|
208 |
2 |
p. 223-235
|
artikel
|
Tijdschrift beschrijving